The loss of smell and taste with a COVID-19 infection during the delta surge was a prevalent symptom and wasn't prevented by vaccination, new research suggests.
May 26, 2022
0
189
More than 40 million Americans take statins, the most common type of prescription drug. While statins have been shown to effectively lower cholesterol levels and reduce the risks of stroke and heart attack, they do not work ...
May 11, 2022
0
124
COVID-19 is mainly known as a respiratory ailment, but a new study suggests the coronavirus can infect your intestinal tract for weeks and months after you've cleared the bug from your lungs.
Apr 18, 2022
0
340
Clinical trials are a pivotal tool for assessing the safety and efficacy of medical interventions, but sponsors often provide incomplete information for assessing their ethical justification. Researchers publishing in the ...
Apr 8, 2022
0
22
The findings of a new study suggest that a ketogenic diet—which is low in carbohydrates and protein, but high in fat—helps to kill pancreatic cancer cells when combined with a triple-drug therapy developed by the Translational ...
Mar 21, 2022
0
76
A clinical trial conducted by researchers from RCSI University of Medicine and Health Sciences and Beaumont Hospital Dublin has indicated an effective treatment for critically ill COVID-19 patients.
Mar 11, 2022
0
73
A Ludwig Cancer Research preclinical study has demonstrated that a common weight-loss diet could enhance the efficacy of chemotherapy for pancreatic cancer. Published in the journal Med, the study shows that a ketogenic ...
Feb 11, 2022
0
199
Ambient temperature influences the results of some of the most used laboratory tests, and these distortions likely affect medical decision making, such as whether to prescribe medications, researchers report December 10th ...
Dec 10, 2021
1
24
People who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors—a class of immunosuppressants used to treat rheumatoid arthritis and other autoimmune conditions—generated less powerful and shorter-lived ...
Nov 19, 2021
0
137
A therapeutic antibody developed by scientists at UCL has been shown to unblock and normalize blood vessels inside cancerous tumors, enabling the more effective delivery of targeted cancer treatments.
Nov 3, 2021
0
80
